FENLAND GROUP PRACTICE
THE SURGERY, 4 CATHEDRAL VIEW, MANEA, MARCHHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 5 | 5 | 100.0% | |
HF 4 | 2011 | 5 | 6 | 83.3% | |
HF 4 | 2012 | 3 | 3 | 100.0% | |
HF 4 | 2013 | 3 | 3 | 100.0% | |
HF004 | 2014 | 1 | 1 | 100.0% | |
HF004 | 2015 | 0 | 0 | NA% | |
HF004 | 2016 | 1 | 1 | 100.0% | |
HF004 | 2017 | 1 | 2 | 50.0% | |
HF004 | 2018 | 10 | 12 | 83.3% | |
HF004 | 2019 | 16 | 18 | 88.9% | |
HF004 | 2020 | 18 | 21 | 85.7% | |
HF006 | 2021 | 23 | 28 | 82.1% | |
HF006 | 2022 | 24 | 29 | 82.8% | |
HF006 | 2023 | 87 | 97 | 89.7% |